These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 30524438)

  • 1. Specific MHC-I Peptides Are Induced Using PROTACs.
    Jensen SM; Potts GK; Ready DB; Patterson MJ
    Front Immunol; 2018; 9():2697. PubMed ID: 30524438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC class I antigen presentation--recently trimmed and well presented.
    Flutter B; Gao B
    Cell Mol Immunol; 2004 Feb; 1(1):22-30. PubMed ID: 16212917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for purification and identification of MHC class I immunopeptidome from cancer cell lines.
    Mohan SV; Datta KK; Ziegman R; Smith C; Gowda H
    STAR Protoc; 2021 Mar; 2(1):100385. PubMed ID: 33778779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The canine MHC class Ia allele DLA-88*508:01 presents diverse self- and canine distemper virus-origin peptides of varying length that have a conserved binding motif.
    Ross P; Nemec PS; Kapatos A; Miller KR; Holmes JC; Suter SE; Buntzman AS; Soderblom EJ; Collins EJ; Hess PR
    Vet Immunol Immunopathol; 2018 Mar; 197():76-86. PubMed ID: 29475511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Secondary Structure Biases in Naturally Presented HLA-I Ligands.
    Perez MAS; Bassani-Sternberg M; Coukos G; Gfeller D; Zoete V
    Front Immunol; 2019; 10():2731. PubMed ID: 31824508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides bound to major histocompatibility complex molecules.
    Maffei A; Harris PE
    Peptides; 1998; 19(1):179-98. PubMed ID: 9437752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major histocompatibility complex class I presentation of exogenous and endogenous protein-derived peptides by a transfected human monocyte cell line.
    Harris PE; Colovai AI; Maffei A; Liu Z; Foca NS
    Immunology; 1995 Dec; 86(4):606-11. PubMed ID: 8567028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standard and immunoproteasomes show similar peptide degradation specificities.
    Zanker D; Chen W
    Eur J Immunol; 2014 Dec; 44(12):3500-3. PubMed ID: 25399798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the Deubiquitinase Usp14 Diminishes Direct MHC Class I Antigen Presentation.
    Palmer AL; de Jong A; Leestemaker Y; Geurink PP; Wijdeven RH; Ovaa H; Dolan BP
    J Immunol; 2018 Feb; 200(3):928-936. PubMed ID: 29282303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular architecture of the MHC I peptide-loading complex: one tapasin molecule is essential and sufficient for antigen processing.
    Hulpke S; Baldauf C; Tampé R
    FASEB J; 2012 Dec; 26(12):5071-80. PubMed ID: 22923333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversified Anchoring Features the Peptide Presentation of DLA-88*50801: First Structural Insight into Domestic Dog MHC Class I.
    Xiao J; Xiang W; Chai Y; Haywood J; Qi J; Ba L; Qi P; Wang M; Liu J; Gao GF
    J Immunol; 2016 Sep; 197(6):2306-15. PubMed ID: 27511732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting HIV-1 Gag into the defective ribosomal product pathway enhances MHC class I antigen presentation and CD8+ T cell activation.
    Goldwich A; Hahn SS; Schreiber S; Meier S; Kämpgen E; Wagner R; Lutz MB; Schubert U
    J Immunol; 2008 Jan; 180(1):372-82. PubMed ID: 18097038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of intracellular targets of a small compound by analyzing peptides presented on MHC class I.
    Sugimoto Y; Murohashi M; Arakawa S; Honda S; Shimizu S
    Biochem Biophys Res Commun; 2019 Jan; 508(2):480-486. PubMed ID: 30503339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leucine aminopeptidase is not essential for trimming peptides in the cytosol or generating epitopes for MHC class I antigen presentation.
    Towne CF; York IA; Neijssen J; Karow ML; Murphy AJ; Valenzuela DM; Yancopoulos GD; Neefjes JJ; Rock KL
    J Immunol; 2005 Nov; 175(10):6605-14. PubMed ID: 16272315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects.
    Miura N; Akita H; Tateshita N; Nakamura T; Harashima H
    Mol Ther; 2017 Apr; 25(4):1003-1013. PubMed ID: 28236573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells.
    Peters HL; Tripathi SC; Kerros C; Katayama H; Garber HR; St John LS; Federico L; Meraz IM; Roth JA; Sepesi B; Majidi M; Ruisaard K; Clise-Dwyer K; Roszik J; Gibbons DL; Heymach JV; Swisher SG; Bernatchez C; Alatrash G; Hanash S; Molldrem JJ
    Cancer Immunol Res; 2017 Apr; 5(4):319-329. PubMed ID: 28254787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of peptides associated with class I and class II MHC molecules.
    Engelhard VH
    Annu Rev Immunol; 1994; 12():181-207. PubMed ID: 7516668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Plasticity and Peptide Editing in the MHC I Antigen Processing Pathway.
    Elliott T; van Hateren A
    Biochemistry; 2018 Mar; 57(9):1423-1425. PubMed ID: 29468875
    [No Abstract]   [Full Text] [Related]  

  • 19. MHC class I antigen processing pathways.
    Maffei A; Papadopoulos K; Harris PE
    Hum Immunol; 1997 May; 54(2):91-103. PubMed ID: 9297528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-Specific Prediction of Peptide-MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity.
    Rasmussen M; Fenoy E; Harndahl M; Kristensen AB; Nielsen IK; Nielsen M; Buus S
    J Immunol; 2016 Aug; 197(4):1517-24. PubMed ID: 27402703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.